Comments

Novo Nordisk

Q: What sector and industry does Novo Nordisk (NVO) operate in?

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

NVONYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$87.37

-1.34-1.51%

At close: -

$87.44

0.070.08%

After Hours: 4:59 PM EDT

Novo Nordisk (NVO) Forecast

News Earnings Novo Nordisk (NVO) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Overview Rating

Good

Technicals Analysis

0100

Financials Analysis

0100

Novo Nordisk (NYSE:NVO) Stock Quotes, Forecast and News Summary

Novo Nordisk Stock (NYSE: NVO) stock price, news, charts, stock research, profile.

Open	$88.90
Close	$87.37
Volume / Avg.	4.77M / 6.28M
Day Range	$87.07 - $88.98
52 Wk Range	81.50 - 148.15
Market Cap	$388.35B
P/E Ratio	30.11
Dividend Yield	1.63%
Exchange	NYSE
RSI	36
Short Interest	0.18%
Days to Cover	1

Recent News

Tech Stocks Eye Christmas Gains, Microstrategy Tumbles As Bitcoin Dips To $93,000: What's Driving Markets Monday?

Tech stocks began Christmas week with positive momentum, as the Nasdaq 100 rose 0.4% on Monday, building on a 0.7% gain from Friday. The index has now recovered nearly half of the losses sustained following the Federal Reserve's recent policy meeting. Semiconductors stood out as the top-performing sector:

Piero Cingari

Novo Nordisk Rises 5% In Premarket As Analyst Dismisses Friday's 17% Plunge As Market Overreaction

Analysts at Intron Health, led by Naresh Chouhan, suggested that Friday's market reaction was excessively severe.

Pooja Rajkumari

Novo Nordisk, Super Micro Computer And Arm Are Among Top Large Cap Losers Last Week (December 16-20): Are The Others In Your Portfolio?

11 worst-performing large-cap stocks: NVO, VRTX, XPO, SMCI, NU, ARM, MU, PAYC, CTAS, WBD, MNDY. Blame fiscal spending package, Fed rate hike, weak earnings.

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$88.90
Close	$87.37
Volume / Avg.	4.77M / 6.28M
Day Range	$87.07 - $88.98
52 Wk Range	81.50 - 148.15
Market Cap	$388.35B
P/E Ratio	30.11
Dividend Yield	1.63%
Exchange	NYSE
RSI	36
Short Interest	0.18%
Days to Cover	1

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Novo Nordisk (NVO) stock?

You can purchase shares of Novo Nordisk (NYSE:NVO) through any online brokerage.

View our list of the best stock brokerages

Who are Novo Nordisk (NVO) competitors?

Other companies in Novo Nordisk’s space includes: Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

What is the forecast, or price target, for Novo Nordisk (NVO) stock?

Novo Nordisk has a consensus price target of $116.57.

What is the current price for Novo Nordisk (NVO)?

The stock price for Novo Nordisk (NYSE: NVO) is $87.44 last updated December 24, 2024 at 4:59 PM EST.

Does Novo Nordisk (NVO) pay a dividend?

A quarterly cash dividend of 2.50 per share of Class A Common Stock. The quarterly cash dividend was payable on April 2, 2012 to stockholders of record on March 22, 2012.

When is Novo Nordisk (NYSE:NVO) reporting earnings?

Novo Nordisk’s Q4 earnings are confirmed for Wednesday, February 5, 2025.

Is Novo Nordisk (NVO) going to split?

There is no upcoming split for Novo Nordisk.

What sector and industry does Novo Nordisk (NVO) operate in?

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.